FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2507526857> ?p ?o ?g. }

• W2507526857 endingPage "700" @default.
• W2507526857 startingPage "678" @default.
• W2507526857 abstract "Tapentadol prolonged release (PR) for the treatment of moderate to severe chronic pain combines 2 modes of action. These are μ-opioid receptor agonism and noradrenaline reuptake inhibition in a single molecule that allow higher analgesic potency through modulation of different pharmacological targets within the pain transmitting systems. At the same time, this can also serve as a clue for modulation of different pain-generating mechanisms according to nociceptive, neuropathic, or mixed pain conditions. Tapentadol PR has now been on the market for 5 years, with over 4.6 million people treated worldwide. A panel of pain specialists convened in Germany to review the clinical program and to discuss the role of tapentadol PR in the management of chronic pain. The clinical study program demonstrated effective and generally well-tolerated treatment for up to 2 years in a broad range of chronic pain conditions, including those with neuropathic pain components. This was confirmed in routine clinical practice observations. Head-to-head studies with World Health Organization (WHO) III opioids such as oxycodone controlled release and oxycodone/naloxone PR showed at least comparable pain relief in the treatment of moderate-to-severe musculoskeletal pain. Rotation from poorly tolerated WHO III opioids to tapentadol PR provided effective pain relief and better symptom control for musculoskeletal pain compared to previous medication. Functionality, health status and quality of life also improved under tapentadol PR treatment. The gastrointestinal tolerability profile was more favorable compared to other tested WHO III opioids. Tapentadol PR has a good safety profile and no evidence of acquired tolerance from the long-term data so far collected. Overall, tapentadol PR represents an effective and generally well-tolerated alternative to classical opioidergic drugs." @default.
• W2507526857 created "2016-09-16" @default.
• W2507526857 creator A5006434120 @default.
• W2507526857 creator A5011006396 @default.
• W2507526857 creator A5014651444 @default.
• W2507526857 creator A5015312435 @default.
• W2507526857 creator A5027284020 @default.
• W2507526857 creator A5054478282 @default.
• W2507526857 creator A5088927728 @default.
• W2507526857 date "2016-10-25" @default.
• W2507526857 modified "2023-10-13" @default.
• W2507526857 title "Tapentadol Prolonged Release for Chronic Pain: A Review of Clinical Trials and 5 Years of Routine Clinical Practice Data" @default.
• W2507526857 cites W142954314 @default.
• W2507526857 cites W15160254 @default.
• W2507526857 cites W1562338169 @default.
• W2507526857 cites W1576916298 @default.
• W2507526857 cites W175348383 @default.
• W2507526857 cites W1809058072 @default.
• W2507526857 cites W1857966818 @default.
• W2507526857 cites W1965999023 @default.
• W2507526857 cites W1977747357 @default.
• W2507526857 cites W1980075122 @default.
• W2507526857 cites W1980190867 @default.
• W2507526857 cites W1991790545 @default.
• W2507526857 cites W1995468922 @default.
• W2507526857 cites W2000889035 @default.
• W2507526857 cites W2003069609 @default.
• W2507526857 cites W2004264116 @default.
• W2507526857 cites W2007493107 @default.
• W2507526857 cites W2013491570 @default.
• W2507526857 cites W2016122617 @default.
• W2507526857 cites W2018914766 @default.
• W2507526857 cites W2025460519 @default.
• W2507526857 cites W2026519602 @default.
• W2507526857 cites W2028140282 @default.
• W2507526857 cites W2031905800 @default.
• W2507526857 cites W2042549287 @default.
• W2507526857 cites W2045707303 @default.
• W2507526857 cites W2054069591 @default.
• W2507526857 cites W2060302340 @default.
• W2507526857 cites W2063137468 @default.
• W2507526857 cites W2066553562 @default.
• W2507526857 cites W2083213461 @default.
• W2507526857 cites W2084567915 @default.
• W2507526857 cites W2088245228 @default.
• W2507526857 cites W2095025301 @default.
• W2507526857 cites W2105991832 @default.
• W2507526857 cites W2114341681 @default.
• W2507526857 cites W2123758210 @default.
• W2507526857 cites W2125285910 @default.
• W2507526857 cites W2126390848 @default.
• W2507526857 cites W2133531206 @default.
• W2507526857 cites W2138446311 @default.
• W2507526857 cites W2146656145 @default.
• W2507526857 cites W2154693681 @default.
• W2507526857 cites W2155412494 @default.
• W2507526857 cites W2157999436 @default.
• W2507526857 cites W2158017724 @default.
• W2507526857 cites W2159758574 @default.
• W2507526857 cites W2160842604 @default.
• W2507526857 cites W2167613032 @default.
• W2507526857 cites W2341767059 @default.
• W2507526857 cites W2473786944 @default.
• W2507526857 cites W3130168933 @default.
• W2507526857 cites W3212431562 @default.
• W2507526857 cites W4230873417 @default.
• W2507526857 cites W4292806894 @default.
• W2507526857 cites W89558675 @default.
• W2507526857 doi "https://doi.org/10.1111/papr.12515" @default.
• W2507526857 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27611642" @default.
• W2507526857 hasPublicationYear "2016" @default.
• W2507526857 type Work @default.
• W2507526857 sameAs 2507526857 @default.
• W2507526857 citedByCount "41" @default.
• W2507526857 countsByYear W25075268572017 @default.
• W2507526857 countsByYear W25075268572018 @default.
• W2507526857 countsByYear W25075268572019 @default.
• W2507526857 countsByYear W25075268572020 @default.
• W2507526857 countsByYear W25075268572021 @default.
• W2507526857 countsByYear W25075268572022 @default.
• W2507526857 countsByYear W25075268572023 @default.
• W2507526857 crossrefType "journal-article" @default.
• W2507526857 hasAuthorship W2507526857A5006434120 @default.
• W2507526857 hasAuthorship W2507526857A5011006396 @default.
• W2507526857 hasAuthorship W2507526857A5014651444 @default.
• W2507526857 hasAuthorship W2507526857A5015312435 @default.
• W2507526857 hasAuthorship W2507526857A5027284020 @default.
• W2507526857 hasAuthorship W2507526857A5054478282 @default.
• W2507526857 hasAuthorship W2507526857A5088927728 @default.
• W2507526857 hasBestOaLocation W25075268571 @default.
• W2507526857 hasConcept C126322002 @default.
• W2507526857 hasConcept C170493617 @default.
• W2507526857 hasConcept C1862650 @default.
• W2507526857 hasConcept C197934379 @default.
• W2507526857 hasConcept C2776029756 @default.
• W2507526857 hasConcept C2777107010 @default.
• W2507526857 hasConcept C2778375690 @default.
• W2507526857 hasConcept C2780505013 @default.

• next